Total planned funding: $2,309,744,638
Clear active filters
Nigeria
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $2,309,744,638 |
Organizational Types
NGO | $709,637,937 |
Private Contractor | $449,244,771 |
University | $372,317,894 |
Unknown | $353,437,782 |
Own Agency | $146,995,914 |
FBO | $103,144,245 |
Implementing Agency | $83,350,136 |
Host Country Government Agency | $48,595,689 |
Other USG Agency | $39,440,271 |
Multi-lateral Agency | $3,579,999 |
Program Areas
Treatment | $878,863,840 |
Care | $434,968,780 |
Governance and Systems | $397,668,345 |
Prevention | $383,018,589 |
Management and Operations | $114,546,717 |
Testing | $100,678,367 |
Budget Codes
HTXD: Treatment: ARV Drugs | $446,813,447 |
HTXS: Treatment: Adult Treatment | $402,444,281 |
HLAB: Laboratory Infrastructure | $191,469,786 |
HKID: Care: Orphans and Vulnerable Children | $184,129,952 |
HBHC: Care: Adult Care and Support | $169,878,593 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $164,695,154 |
OHSS: Health Systems Strengthening | $118,420,600 |
HVMS: Management and Operations | $114,546,717 |
HVCT: Testing: HIV Testing and Counseling | $100,678,367 |
HVOP: Sexual Prevention: Other Sexual Prevention | $89,177,616 |
HVSI: Strategic Information | $87,777,959 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $76,508,588 |
HVTB: Care: TB/HIV | $65,571,548 |
HMBL: Biomedical Prevention: Blood Safety | $33,195,771 |
PDTX: Treatment: Pediatric Treatment | $29,606,112 |
HMIN: Biomedical Prevention: Injection Safety | $19,441,460 |
PDCS: Care: Pediatric Care and Support | $15,388,687 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
FHI 360:
$325,774,355
Countries/Regions
Not Available:
$298,516,001
Countries/Regions
Harvard University:
$153,090,978
Countries/Regions
University of Maryland:
$140,403,074
Countries/Regions